Do you want to read an article? Please log in or register.
Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study.
Diabetes - GeneralType 2 DiabetesGlycemic Control
Related content
Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalisation and mortality records.
Diabetes Obes Metab.
Zghebi SS, Steinke DT, Rutter MK, Emsley RA, Ashcroft DM
doi: 10.1111/dom.12692.
RECOMMENDED
Type 2 Diabetes
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin - A DEVOTE subanalysis (DEVOTE 10)
Diabetes Obes Metab.
Brown-Frandsen K, Emerson SS, McGuire DK, Pieber TR, Poulter NR, Pratley RE, Zinman B, Ranthe MF, Grøn R, Lange M, Moses AC, Őrsy P, Buse JB, DEVOTE Study Group
doi: 10.1111/dom.13677.
COMMENTED
Type 2 Diabetes
Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality for Widely Used Antihyperglycemic Dual and Triple Therapies for Type 2 Diabetes Management: A Cohort Study of All Danish Users
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.2337/dc19-2535.
COMMENTED
Type 2 Diabetes
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
Lancet Diabetes Endocrinol.
Svanström H, Ueda P, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B
doi: 10.1016/S2213-
COMMENTED
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study
Lancet.
Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, Iqbal R, Kumar R, Wentzel-Viljoen E, Rosengren A, Amma LI, Avezum A, Chifamba J, Diaz R, Khatib R, Lear S, Lopez-Jaramillo P, Liu X, Gupta R, Mohammadifard N, Gao N, Oguz A, Ramli AS, Seron P, Sun Y, Szuba A, Tsolekile L, Wielgosz A, Yusuf R, Hussein Yusufali A, Teo KK, Rangarajan S, Dagenais G, Bangdiwala SI, Islam S, Anand SS, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study investigators
doi: 10.1016/
Type 2 DiabetesGlycemic Control
A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study
Diabetologia
Heller SR, Geybels MS, Iqbal A, Liu L, Wagner L, Chow E
doi: 10.1007/s00125-021-05556-7
COMMENTED
Type 2 DiabetesObesity and Bariatric Surgery
Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity
JAMA.
Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE
doi: 10.1001/jama.2019.14231.
COMMENTED
Diabetes - General
Statin therapy for primary prevention in the elderly and its association with new-onset diabetes, cardiovascular events and all-cause mortality
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Med
Lavie G, Hoshen M, Leibowitz M, Benis A, Akriv A, Balicer R, Reges O
doi: 10.1016/j.amjmed.2020.09.058
COMMENTED
Thyroid
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study
Lancet Diabetes Endocrinol.
Okosieme OE, Taylor PN, Evans C, Thayer D, Chai A, Khan I, Draman MS, Tennant B, Geen J, Sayers A, French R, Lazarus JH, Premawardhana LD,
Dayan CM
doi: 10.1016/S2213-8587(19)30059-2.